Preferred Label : dideoxynucleosides;

MeSH definition : Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription.;

MeSH synonym : ddnus;

MeSH hyponym : 2',3'-Dideoxynucleosides; dideoxyribonucleosides; 2',3' Dideoxynucleosides;

MeSH annotation : antivirals & antimetabolites;

Is substance : O;

Details


Main resources

You can consult :

Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription.

http://www.has-sante.fr/portail/jcms/c_779534/detection-de-l-allele-hla-b5701-prealable-au-traitement-par-abacavir
2016
false
false
false
France
French
drug hypersensitivity
genetic testing
abacavir
drug hypersensitivity
HLA-B*57:01 antigen
HLA-B*5701 assay
health technology assessment
reverse transcriptase inhibitors
hypersensitivity, delayed
mass screening
dideoxynucleosides
HLA-B antigens

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=64287253
2015
false
false
false
France
French
summary of product characteristics
evaluation of the transparency committee
package leaflet
lamivudine, abacavir and dolutegravir
lamivudine
abacavir sulfate
dolutegravir sodium
drug combinations
abacavir
dolutegravir
dideoxynucleosides
heterocyclic compounds, 3-ring

---
http://www.has-sante.fr/portail/jcms/c_2559109/fr/kivexa
2015
false
false
false
France
French
evaluation of the transparency committee
dideoxynucleosides
lamivudine
drug combinations

---
https://www.ema.europa.eu/medicines/human/EPAR/Triumeq
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
abacavir sulfate
abacavir sulfate
dolutegravir sodium
dolutegravir sodium
lamivudine
lamivudine
anti-hiv agents
anti-hiv agents
hiv infections
adolescent
adult
aged
administration, oral
tablets
lamivudine, abacavir and dolutegravir
HLA-B*57:01 antigen
genetic testing
drug hypersensitivity
reverse transcriptase inhibitors
reverse transcriptase inhibitors
HIV integrase inhibitors
HIV integrase inhibitors
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
abacavir
abacavir
HLA-B antigens
dideoxynucleosides
dideoxynucleosides

---
http://www.has-sante.fr/portail/jcms/c_2008464/fr/triumeq
http://www.has-sante.fr/portail/jcms/c_2008464/fr/triumeq-dolutegravir/abacavir/lamivudine-association-fixe-d-antiretroviraux
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
administration, oral
insurance, health, reimbursement
treatment outcome
drug combinations
dolutegravir
dolutegravir
abacavir
abacavir
lamivudine
lamivudine
lamivudine, abacavir and dolutegravir
reverse transcriptase inhibitors
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
HIV integrase inhibitors
HIV integrase inhibitors
adult
adolescent
hiv infections
HIV-1
HLA-B*57:01 antigen
human immunodeficiency virus i infection
Contraindications, Procedure
heterocyclic compounds, 3-ring
heterocyclic compounds, 3-ring
dideoxynucleosides
dideoxynucleosides
HLA-B antigens
Contraindications, Drug

---
http://www.has-sante.fr/portail/jcms/c_718918/trizivir
2008
France
French
reverse transcriptase inhibitors
lamivudine
dideoxynucleosides
drug combinations
zidovudine
administration, oral
tablets
insurance, health, reimbursement
anti-hiv agents
adult
hiv infections
genetic testing
HLA-B antigens
drug hypersensitivity
abacavir
abacavir, lamivudine, and zidovudine drug combination
HLA-B*57:01 antigen
zidovudine, lamivudine and abacavir
abacavir sulfate
dideoxynucleosides
HLA-B antigens
evaluation of the transparency committee

---
Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.